Taking all factors into account, our results demonstrate that FBLN7 is a key regulator of myocardial fibrosis in the context of aging and reveals its potential to reverse the impaired profibrotic phenotypes of senescent CFs, which may contribute to the pathogenesis of age-related cardiac fibrosis. Here, FBLN7 is linked to Myocardial fibrosis.